Masayuki Kurosaki

Long‐term clinical outcomes in steatotic liver disease and incidence of liver‐related events, cardiovascular events and all‐cause mortality

Nobuharu Tamaki, Takefumi Kimura, Shun‐ichi Wakabayashi et al. · Alimentary Pharmacology & Therapeutics · 2024 · 47 citations

Characteristics of hepatitis C viral genome associated with disease progression

Kazuyoshi Nagayama, Masayuki Kurosaki, N Enomoto et al. · Hepatology · 2000 · 37 citations

Natural history of lean and non-lean metabolic dysfunction-associated steatotic liver disease

Shun‐ichi Wakabayashi, Nobuharu Tamaki, Takefumi Kimura et al. · Journal of Gastroenterology · 2024 · 28 citations

Metabolic Disorder, Pathology, Fatty Liver Disease +17

Glycemic control target for liver and cardiovascular events risk in metabolic dysfunction‐associated steatotic liver disease

Nobuharu Tamaki, Shun‐ichi Wakabayashi, Takefumi Kimura et al. · Hepatology Research · 2024 · 20 citations

Overexpression of interferon γ-inducible protein 10 in the liver of patients with type i autoimmune hepatitis identified by suppression subtractive hybridization

Kazuyoshi Nagayama, Nobuyuki Enomoto, Yuka Miyasaka et al. · The American Journal of Gastroenterology · 2001 · 17 citations